Compare IQV & UMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | UMC |
|---|---|---|
| Founded | 1982 | 1980 |
| Country | United States | Taiwan |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6B | 29.3B |
| IPO Year | 2013 | 1997 |
| Metric | IQV | UMC |
|---|---|---|
| Price | $203.92 | $24.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $227.13 | N/A |
| AVG Volume (30 Days) | 1.5M | ★ 17.7M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.92% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 1.61 | N/A |
| Revenue | ★ $9,739,000,000.00 | N/A |
| Revenue This Year | $6.77 | $11.22 |
| Revenue Next Year | $5.89 | $10.15 |
| P/E Ratio | $129.54 | ★ $18.95 |
| Revenue Growth | ★ 41.60 | N/A |
| 52 Week Low | $154.50 | $6.56 |
| 52 Week High | $247.05 | $28.96 |
| Indicator | IQV | UMC |
|---|---|---|
| Relative Strength Index (RSI) | 66.57 | 54.18 |
| Support Level | $159.91 | $7.56 |
| Resistance Level | $209.48 | $28.96 |
| Average True Range (ATR) | 7.02 | 1.36 |
| MACD | 2.45 | -0.43 |
| Stochastic Oscillator | 84.77 | 39.92 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 5% market share in 2024 after TSMC and SMIC. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the US, and South Korea. UMC features a diverse customer base that includes Texas Instruments, MediaTek, Intel, Broadcom, Novatek, and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 19,000 people as of February 2025.